Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fibroblast growth factor receptor (FGFR) family is a group of receptor tyrosine kinases that play essential roles in cell signaling, development, tissue homeostasis, and disease. The family consists of four main members: FGFR1, FGFR2, FGFR3, and FGFR4. A fifth member (FGFR5) has been identified but lacks the intracellular kinase domain present in the others. FGFRs bind to fibroblast growth factors (FGFs), and upon ligand binding, dimerize and transautophosphorylate, initiating downstream signaling cascades involved in proliferation, differentiation, migration, survival, angiogenesis, and metabolic regulation. Dysregulation or mutation of FGFR genes is implicated in various diseases, including cancers and congenital disorders.
Tyrosine kinase inhibition
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibroblast Growth Factor Receptor Family (FGFR).